<SEC-DOCUMENT>0001279569-19-000044.txt : 20190109
<SEC-HEADER>0001279569-19-000044.hdr.sgml : 20190109
<ACCEPTANCE-DATETIME>20190109142245
ACCESSION NUMBER:		0001279569-19-000044
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20190109
FILED AS OF DATE:		20190109
DATE AS OF CHANGE:		20190109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Canopy Growth Corp
		CENTRAL INDEX KEY:			0001737927
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38496
		FILM NUMBER:		19518000

	BUSINESS ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
		BUSINESS PHONE:		855-558-9333

	MAIL ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>canopy6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0 0 3pt">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"></p>

<!-- Field: Rule-Page --><div align="left" style="margin-top: 12pt; margin-bottom: 3pt"><div style="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION
</b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, D.C. 20549 </b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>FORM&nbsp;6-K </b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>REPORT OF FOREIGN ISSUER </b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PURSUANT TO RULE 13a-16 OR 15d-16
</b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>OF THE SECURITIES EXCHANGE ACT OF
1934 </b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>For the month of January
2019</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Commission File No.&nbsp;001-38496</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 24pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Canopy Growth Corporation</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>1 Hershey Drive<br>
Smith Falls, Ontario<br>
K7A 0A8</b></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark whether the registrant files
or will file annual reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Form&nbsp;20-F&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font>
<font style="font-family: Times New Roman, Times, Serif">Form 40-F&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting
the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101&nbsp;(b)&nbsp;(1):</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting
the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101&nbsp;(b)&nbsp;(7):</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark whether the registrant by furnishing
the information contained in this Form&nbsp;is also thereby furnishing the information to the Commission pursuant to Rule&nbsp;12g3-2(b)&nbsp;under
the Securities Exchange Act of 1934.</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font>
<font style="font-family: Times New Roman, Times, Serif">&nbsp;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<!-- Field: Rule-Page --><div align="left" style="margin-top: 3pt; margin-bottom: 12pt"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>EXHIBIT INDEX </b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 8%">&nbsp;</td>
    <td style="width: 2%">&nbsp;</td>
    <td style="width: 90%">&nbsp;</td></tr>
<tr>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap>
        <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Exhibit</b></p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td>
    <td>&nbsp;</td>
    <td nowrap>
        <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"><b>Description</b></p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td></tr>
<tr style="vertical-align: top">
    <td nowrap style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><A HREF="ex991.htm">99.1</A></FONT></td>
    <td><FONT STYLE="color: Black">&nbsp;</FONT></td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><A HREF="ex991.htm">Press
    Release - Canopy LATAM starting the year strong - opening new markets, supporting education, and achieving newly licensed
production capacity</A></FONT></td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">1</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;&nbsp;</p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"><u></u></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 50%">&nbsp;</td>
    <td style="width: 7%">&nbsp;</td>
    <td style="width: 43%">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td colspan="2" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canopy Growth Corporation</font></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td colspan="2" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
    <td style="vertical-align: bottom">
        <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">/s/ Bruce Linton</p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</font></td>
    <td style="vertical-align: bottom; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce Linton</font></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</font></td>
    <td style="vertical-align: bottom; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</font></td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Date: January 9, 2019</p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0.25in 0 0"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">2</p>




<p style="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991.htm
<DESCRIPTION>NEWS RELEASE DATED JANUARY 9, 2019
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 24pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: bold 14pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Canopy LATAM starting the year strong
- opening new markets, supporting education, and achieving newly licensed production capacity</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">LIMA, Peru&nbsp;and SMITHS FALLS, ON, Jan.
9, 2019 /CNW/ -&nbsp;Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the &quot;Company&quot; or &quot;Canopy Growth&quot;),
through its Latin American-focused subsidiary, Canopy LATAM Corporation (&quot;Canopy LATAM&quot;), is proud to introduce Spectrum
Cannabis Peru S.A.C. (&quot;Spectrum Cannabis Peru&quot;), the newest member of the growing global Spectrum Cannabis family.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Spectrum Cannabis Peru will operate as part
of the Canopy LATAM network and with Peru poised to introduce new regulations for the use of medical cannabis, this new in-market
entity is uniquely positioned to support the opening of the Peruvian market while leveraging Canopy Growth's global expertise in
patient and physician education, as well as in medical cannabis production.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">This announcement directly supports Canopy
Growth's strategy of securing first mover advantage to realize the opportunities generated by evolving cannabis regulations across
the region and the world. Until regulations are published supporting patient access to medical cannabis, Spectrum Cannabis Peru
will focus on advancing education activities, including working closely with the medical community to foster greater understanding
of the potential uses of medical cannabis while reducing stigma.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Supporting education, regulation, and patient
access for medical cannabis across Latin America</B></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">While in Lima to participate in the launch
of Spectrum Cannabis Peru, Dr. Mark Ware, Canopy Growth's Chief Medical Officer, is advancing the Company's commitment to education
through participation in a range of medical cannabis-focused events for physicians, healthcare professionals, and cannabis-focused
patient groups.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">This includes addressing healthcare professionals
currently attending an introductory course on cannabis held by the medical college of Peru (&quot;Colegio Medico del Peru&quot;),
as well as delivering an address and participating in the First Meeting of American Professional Experts working with Phytocannabinoids
(&quot;1&deg; Encuentro Americano De Professionales Expertos En Fitocannabioides&quot;) held in Lima from January 10 to 11.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The conference will also see Dr. Ware, in his
capacity as a family physician focused on pain management, participate in the signing of the Lima Declaration on the medical use
of cannabis. This physician-led declaration encourages governments, regulators, and health authorities throughout the region to
ensure patient access and scientific research are the cornerstones of all Latin America medical cannabis laws.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Further, the declaration promotes collaboration
across the region, and calls on healthcare professionals to contribute to informed access for cannabis-based medicines while asking
patients to advocate and defend their right to such treatments.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>A leap forward for sustainable regional
production through Spectrum Cannabis Colombia</B></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">As previously announced, production operations
are advancing at the Company's farm in Colombia, with initial cultivation having started in late 2018. In line with the plan for
sustainable regional production based in the country, the Company is pleased to report that licenses have now been received for
the production of cannabis in all 126 hectares (13.6 million sq. ft.) of suitable growing area at the farm.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">This is an increase from the previously licensed
42 hectares (4.5 million sq. ft.) of production area and to the Company's knowledge, the wholly owned farm now represents one of
the largest fully licensed cannabis production facilities in the world. This also positions Canopy Growth to meet the emerging
regional supply demands as a number of countries across Latin America update their regulations and in so doing, open their markets
for the import and sale of Spectrum Cannabis' high-quality cannabis-based medical products.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Continued development of Canopy LATAM and
local in-market entities</B></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">As regulations across the region continue to
evolve at a rapid pace, Canopy Growth is well positioned to seize these new opportunities through its subsidiary Canopy LATAM,
and the in-market entities that work collectively as part of the Company's LATAM structure. A full leadership team is now in place
at both the regional and local level to guide these activities and draws on extensive experience from leading organizations in
the pharmaceutical, food and beverage, and consulting industries.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">With a fully licensed production site in Colombia,
newly launched operations in Peru, a rapidly evolving landscape in Mexico, and clinical trials underway in Chile, Canopy LATAM
and Canopy Growth are uniquely positioned to realize the significant opportunities across Latin America with the ultimate goal
of serving patients through education and high quality, reliable, medical cannabis products.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Quotes from leadership</B></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;We're proud to welcome Peru to the growing
family of Spectrum Cannabis countries and to have the chance to serve Peruvian patients and healthcare professionals in the future,&quot;
said Mark Zekulin, President and Co-CEO, Canopy Growth. &quot;Canopy Growth is a global leader in providing safe, regulated, medical
cannabis and by leveraging our experience together with local expertise, we look forward to helping build a responsible Peruvian
cannabis industry today and into the future.&quot;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;The landscape for medical cannabis continues
to evolve rapidly in Latin America and Peru is poised to take a leading role with the introduction of new regulations which we
hope will prioritize patient access&quot;, said Antonio Droghetti, Managing Director, Canopy LATAM. &quot;Launching Peruvian operations
enhances our ability to engage with regulators, healthcare professionals, and patients to ensure they have the information they
need while also preparing for the future sale of medical cannabis products across the country.&quot;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;With the full licensing of our 126-hectare
farm, Spectrum Cannabis Colombia and Canopy Growth have demonstrated yet again our ability to execute and prepare for the rapidly
rising demand that exists for medical cannabis&quot;, said Bibiana Rojas, Country Managing Director, Spectrum Cannabis Colombia.
&quot;Our ambitious goal of sustainable regional production for medical cannabis is one step closer in Latin America and we're
proud to play a role in increasing the total potential production of Canopy Growth as it builds markets internationally.&quot;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>About Canopy Growth Corporation</B><BR>
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties
in dried, oil and Softgel capsule forms. Canopy Growth offers the world's only medically approved vaporizers through the Company's
subsidiary, Storz &amp; Bickel GMbH &amp; Co. KG. From product and process innovation to market execution, Canopy Growth is driven
by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.
The Company has operations in 13 countries across five continents. The Company is proudly dedicated to educating healthcare practitioners,
conducting robust clinical research, and furthering the public's understanding of cannabis, and through its wholly owned subsidiary,
Canopy Health Innovations (&quot;Canopy Health&quot;), has devoted millions of dollars toward cutting edge, commercializable research
and IP development. Canopy Growth works with the Beckley Foundation and has launched Beckley Canopy Therapeutics to research and
develop clinically validated cannabis-based medicines, with a strong focus on intellectual property protection. Canopy Growth acquired
assets of leading hemp research company, ebbu, Inc. (&quot;ebbu&quot;). Intellectual Property (&quot;IP&quot;) and R&amp;D advancements
achieved by ebbu's team apply directly to Canopy Growth's hemp and THC-rich cannabis genetic breeding program and its cannabis-infused
beverage capabilities. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment
to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing on the Toronto
Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through
leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including
cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, Battelle, the world's largest nonprofit research
and development organization, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates ten
licensed cannabis production sites with over 4.3 million square feet of production capacity, including over 500,000 square feet
of GMP certified production space. The Company operates Tweed retail stores in Newfoundland and Manitoba and has entered into supply
agreements with every Canadian province and territory. For more information visit www.canopygrowth.com.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Notice Regarding Forward Looking Statements</B><BR>
This news release contains &quot;forward-looking statements&quot; within the meaning of the United States Private Securities Litigation
Reform Act of 1995 and &quot;forward-looking information&quot; within the meaning of applicable Canadian securities legislation.
Often, but not always, forward-looking statements and information can be identified by the use of words such as &quot;plans&quot;,
&quot;expects&quot; or &quot;does not expect&quot;, &quot;is expected&quot;, &quot;estimates&quot;, &quot;intends&quot;, &quot;anticipates&quot;
or &quot;does not anticipate&quot;, or &quot;believes&quot;, or variations of such words and phrases or state that certain actions,
events or results &quot;may&quot;, &quot;could&quot;, &quot;would&quot;, &quot;might&quot; or &quot;will&quot; be taken, occur
or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which
may cause the actual results, performance or achievements of Canopy Growth or its subsidiaries to be materially different from
any future results, performance or achievements expressed or implied by the forward-looking statements or information contained
in this news release. Examples of such statements include statements with respect to international operations in the LATAM region.
Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance,
prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including
the Company's ability to satisfy provincial sales contracts or provinces purchasing all cannabis allocated to them, and such risks
contained in the Company's annual information form dated June 27, 2018 and filed with Canadian securities regulators available
on the Company's issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used
in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance
should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames
or at all. The forward-looking information and forward-looking statements included in this news release are made as of the date
of this news release and the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking
information to reflect new information, subsequent events or otherwise unless required by applicable securities laws.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">https://www.facebook.com/canopygrowth/&nbsp;<BR>
https://twitter.com/CanopyGrowth</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><IMG SRC="image_002.jpg" ALT="Canopy LATAM" STYLE="height: 38px; width: 128px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><IMG SRC="image_003.jpg" ALT="Cision" STYLE="height: 12px; width: 12px">View
original content to download multimedia:http://www.prnewswire.com/news-releases/canopy-latam-starting-the-year-strong---opening-new-markets-supporting-education-and-achieving-newly-licensed-production-capacity-300775749.html</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SOURCE Canopy Growth Corporation</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia:
http://www.newswire.ca/en/releases/archive/January2019/09/c2387.html</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">%CIK: 0001737927</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><B>For further information: </B>Caitlin O'Hara, Media Relations,
Caitlin.Ohara@canopygrowth.com, 613-291-3239; Investor Relations, Tyler Burns, Tyler.Burns@canopygrowth.com, 855-558-9333 ext.
122; Director: Bruce Linton, tmx@canopygrowth.com</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CO: Canopy Growth Corporation</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CNW 13:00e 09-JAN-19</P>



<P STYLE="font: bold 24pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_[0'@4&AO=&]S:&]P(#,N,  X0DE-! 0
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M%A86%A86%A86%O_  !$( )  D ,!(@ "$0$#$0'_Q  <  $  @,! 0$
M        !@<$!0@# 0+_Q  U$  ! P,$ 0,# @0%!0     ! @,$  41!@<2
M(3$305$(%"(5,B-A<8$6)#-2D0D8)4*2_\0 &@$!  (# 0
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MY)RL_K_3;]SPFE$YTM4"/#MAO35QMQ,7(5&D+')_"NEH3G./CWRGW[K]6O\
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MUH>7$?\ T*_22% %)!!\$53[FI_II2@E3^WP 6\A68L?(4R 7@1QZ],$%?\
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MD]'VA&S\VTQ+%]/UW),32]EN%\AWL2I27&[;?' ZAM3YXI#?)TR@WE*0GUD
M8R,W"YOWM.[,3-<@W1<@$%+RM/.E>1X(5QSU[5Z'?#:K[=YM^VW1IBXA3CWJ
MZ=>X2O\ U)4.'Y^,$G/C^5/%4<ZZH=U9ROH:1ZSP-;_5MJF/;^$O3<O;H634
M[T=04R]*=DK++2E#I3J&%/$^2E+B0<<A5/634NKK3HS16Z%W8GN#9&X#1U[C
MH:RNX<UKA3' /*P.-N4GVY>I[BNA+5O;M;;X;<2VQ;G%CI44MM1]/OMH!/9P
ME* .ZW-DW!TE>D2XEMT]>I24.!R6T+ Z '%$*RM*DC\B0#WWD=]U*%]4WB,D
M_P!D7"<>*(GN9I:W:8^D[4EPOJ8R+^SHF[,RIKK@!,B6RM^2E))Q^;^/YGBD
M5$-\6=.I_P"G?>=21W(7WEQV\A0')B'D_P <-L@MM9S@E*G'<#S^1%79<M7V
MR0T6)ND]22$9"N"]/O.)R.P?VD9J01(%KE6=AL6MA$90#R([L5*0VH]]H(_%
M79SUG.:VD2A]8W"2S]2&R#M[U58YK3RKLN.8L?[?I=MXI.2\X%A1Z& ,GY\5
MT0.Q6"JS6A1:)M<(EA(2T3'1_# .0$]= 'L8K.  &!0"E*4 KY@? K[2@/.2
MRV]'6RL'BXDI5@X.",>:K:^;97!V3%C6_4LUNW)RF47'EB6M/E*0\DC(!)_<
M#Y]QU5FTP*T7:>NY8FB<+)0?E90FK]G&G-3Z=M]NA2U0F(_^=6"D(;PO)5ZA
M Y+7R/D9_ ?-9VG-NM-ZDW$N;4^RMIAV!L0Y00\L"?*40L+)SGBELHPD^"K'
M>,U:FI]26&PO,-W:XLQG9'32%94I7R>(!.![GQ4"T5J[3]AU/K*1>+FW"BS+
MRE^*[(;6A+P^W;!*"1^6"D^/BJJ>BTE5JSC#>_./1'0K[I1X\#7[T[3Z>C:$
MN-WM8>C2+=$<?7AS/W*4)/%"CCPD>/Z#/S6!M'LG&3;(5ROTY,I#H9ELL1R?
M34%)"N+B5 I5W@=#L#O^4CU=N;HS4.WE[BPISSKLBW/-ML&(Z%N%2.*,#C[E
M22/D=U[;=;CZ0M^B+!;[E>&XTA%MC-.!X%/%S'#B?@@H.<] 8^16IZ;03U*E
MNQC]<27>7JK9W\2$:=VU8LLK46IKU;I3\" IY:!*6&E3&4**EJXC!22D''@'
MQCOJ7[3[96'_  M%NUQMOI3YR%OMAMU7^38=*E)CH!. D(7@CW))K/W"UEI2
M^[?ZAM=IO3$R0[;'T)3%2IWDHMG"04@@J\=>1D9K;[?:JLLK3MI@+N3"+A]D
MPA<99*%^IZ8RD)5@DY!_XK=1I-)"U1CAK'\<6R-EMLH9>XC+^S%H$Z2F&^Y'
MA.LJ0PCR8N0!P0/]F>SWGLCWR+%L%IA6F"W'AQFF@EM*5%* "L@ 94?)/7D]
MUGXZI5G3I::6W".#GG9.:\S/F!\#_BOM*5T$!2E* 4I2@%*4H!2E* AUMW!T
M_.O*V@B4U&;G/V]NYO1^$5Z0PE1>0APG.$<' 5D!!4A20HD8J2S(MOND9 ?9
MCRVB.2.:$N)(*2,C.1VDD?T-0_5FW,23%CBUA):C7I%W5:Y4AS[*0Z"XL@I
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)%*4H!2E* __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  F ( # 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#QQ54AF8D
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*P0!BBBL[:%'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ,  P# 2(  A$! Q$!_\0
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?L94\=#@5IJH50HZ 8%8TXM3DWU.BK.+I02Z>7ZG_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
